Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Takeda Pharmaceutical Co Ltd
TSE:4502
Takeda Pharmaceutical Co Ltd
TSE:4502
Price:
5 731
JPY
-0.85%
Market Closed
Market Cap:
¥9.2T
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
JP |
|
B
|
BioMarin Pharmaceutical Inc
SWB:BM8
|
US |
|
MERLIN Properties SOCIMI SA
OTC:MRPRF
|
ES |
|
L
|
Levi Strauss & Co
SWB:LV2B
|
US |
|
K
|
Kiatnakin Phatra Bank PCL
SET:KKP
|
TH |
|
A
|
Ad Pepper Media International NV
SWB:APM
|
DE |
|
V
|
ViTrox Corporation Bhd
KLSE:VITROX
|
MY |
Wall St Price Targets
Price Forecast
Based on 18 analysts
Based on 18 analysts
+19% Upside
from
¥5 731
today
Takeda Pharmaceutical Co Ltd (4502)’s 12-month stock price forecast through October 2027 has a consensus target of ¥6 834, implying 19% upside. The forecast is based on price targets from 18 Wall Street analysts.
Analyst Rating
No ratings yet
No ratings yet
Takeda Pharmaceutical Co Ltd Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Takeda Pharmaceutical Co Ltd's stock price target?
Price Target
6 834
JPY
6 834
JPY
According to Wall Street analysts, the average 1-year price target for Takeda Pharmaceutical Co Ltd is 6 834 JPY with a low forecast of 5 454 JPY and a high forecast of 7 980 JPY.
What is the Revenue forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
3%
3%
Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 3 years is 3%.
What is the Gross Profit forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
4%
4%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 8%. The projected CAGR for the next 3 years is 4%.
What is the Operating Income forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
-24%
-24%
Over the last 13 years, the compound annual growth rate for Operating Income has been 14%. The projected CAGR for the next 1 year is -24%.